Marcal Anglada-Pastor

Av. Diagonal 643
Barcelona, CT 08028, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.

Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.

Journal: Metabolism: clinical and experimental

Published: January 21, 2026

Building together a "trencadís" of nucleotide metabolism.

Building together a "trencadís" of nucleotide metabolism.

Journal: Nucleosides, nucleotides & nucleic acids

Published: December 13, 2025

Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy.

Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy.

Journal: Pharmaceutics

Published: July 01, 2024

RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies.

RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies.

Journal: Bioorganic chemistry

Published: May 08, 2024

Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation.

Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation.

Journal: Molecular pharmaceutics

Published: December 12, 2022

Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29).

Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29).

Journal: International journal of molecular sciences

Published: July 07, 2022

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.

Journal: Pharmaceutics

Published: July 06, 2022

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.

Journal: Cellular and molecular life sciences : CMLS

Published: June 25, 2021

From Inflammation to the Onset of Fibrosis through A2A Receptors in Kidneys from Deceased Donors.

From Inflammation to the Onset of Fibrosis through A2A Receptors in Kidneys from Deceased Donors.

Journal: International journal of molecular sciences

Published: October 15, 2020

Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

Journal: Nucleosides, nucleotides & nucleic acids

Published: April 22, 2020

FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.

FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.

Journal: Pharmacological research

Published: August 02, 2019

Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure.

Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: August 17, 2018

Showing 1-12 of 54

Last Updated: 09/26/2026